Form 4 KALOBIOS PHARMACEUTICALS For: Nov 24 Filed by: Shkreli Martin
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
KaloBios Pharma (KBIO) Could Drop 50% By Early Next Week: Tim Sykes
November 24, 2015 12:46 PM ESTTim Sykes thinks KaloBios Pharma (NASDAQ: KBIO) could drop 50% by early next week, according to the New York... More
KaloBios Pharma (KBIO) CEO Shkreli Bought 5,000 More Shares
November 24, 2015 11:23 AM ESTKaloBios Pharma (NASDAQ: KBIO) CEO Martin Shkreli bought more shares.
Shkreli purchased 5,000 shares on November 24 at $38.15 apiece, according to a Form 4 filed Tuesday.
... More